136 related articles for article (PubMed ID: 25423035)
1. Predictive gene signatures: molecular markers distinguishing colon adenomatous polyp and carcinoma.
Drew JE; Farquharson AJ; Mayer CD; Vase HF; Coates PJ; Steele RJ; Carey FA
PLoS One; 2014; 9(11):e113071. PubMed ID: 25423035
[TBL] [Abstract][Full Text] [Related]
2. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.
Ho SB; Ewing SL; Montgomery CK; Kim YS
Oncol Res; 1996; 8(2):53-61. PubMed ID: 8859775
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
4. The pathophysiology, clinical presentation, and diagnosis of colon cancer and adenomatous polyps.
Cappell MS
Med Clin North Am; 2005 Jan; 89(1):1-42, vii. PubMed ID: 15527807
[TBL] [Abstract][Full Text] [Related]
5. Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in normal colon, polyp, and tumor tissue.
Drew JE; Mayer CD; Farquharson AJ; Young P; Barrera LN
J Mol Diagn; 2011 Mar; 13(2):233-42. PubMed ID: 21354059
[TBL] [Abstract][Full Text] [Related]
6. Colon cancer specific nuclear matrix protein alterations in human colonic adenomatous polyps.
Brünagel G; Schoen RE; Getzenberg RH
J Cell Biochem; 2004 Feb; 91(2):365-74. PubMed ID: 14743395
[TBL] [Abstract][Full Text] [Related]
7. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
[TBL] [Abstract][Full Text] [Related]
8. MMP3 and CXCL1 are potent stromal protein markers of dysplasia-carcinoma transition in sporadic colorectal cancer.
Sipos F; Germann TM; Wichmann B; Galamb O; Spisák S; Krenács T; Tulassay Z; Molnár B; Műzes G
Eur J Cancer Prev; 2014 Sep; 23(5):336-43. PubMed ID: 24999605
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic potential of Fourier-transform infrared microspectroscopy and advanced computational methods in colon cancer patients.
Argov S; Ramesh J; Salman A; Sinelnikov I; Goldstein J; Guterman H; Mordechai S
J Biomed Opt; 2002 Apr; 7(2):248-54. PubMed ID: 11966311
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic microRNAs in stage II colon cancer.
Schepeler T; Reinert JT; Ostenfeld MS; Christensen LL; Silahtaroglu AN; Dyrskjøt L; Wiuf C; Sørensen FJ; Kruhøffer M; Laurberg S; Kauppinen S; Ørntoft TF; Andersen CL
Cancer Res; 2008 Aug; 68(15):6416-24. PubMed ID: 18676867
[TBL] [Abstract][Full Text] [Related]
11. MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes.
Koslowski M; Sahin U; Dhaene K; Huber C; Türeci O
Cancer Res; 2008 May; 68(9):3458-66. PubMed ID: 18451174
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity and p53 gene mutation in familial polyposis coli.
Ikeguchi M; Makino M; Kaibara N
Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
[TBL] [Abstract][Full Text] [Related]
13. [Hereditary solitary adenoma].
Yoshikawa R; Utsunomiya J
Nihon Rinsho; 1995 Nov; 53(11):2734-6. PubMed ID: 8538035
[TBL] [Abstract][Full Text] [Related]
14. In situ validation of an intestinal stem cell signature in colorectal cancer.
Ziskin JL; Dunlap D; Yaylaoglu M; Fodor IK; Forrest WF; Patel R; Ge N; Hutchins GG; Pine JK; Quirke P; Koeppen H; Jubb AM
Gut; 2013 Jul; 62(7):1012-23. PubMed ID: 22637696
[TBL] [Abstract][Full Text] [Related]
15. Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer.
Zhang XM; Zhou C; Gu H; Yan L; Zhang GY
Int J Clin Exp Pathol; 2014; 7(9):5902-8. PubMed ID: 25337233
[TBL] [Abstract][Full Text] [Related]
16. The role of insulin-like growth factor 1 and its receptor in the formation and development of colorectal carcinoma.
Zhang R; Xu GL; Li Y; He LJ; Chen LM; Wang GB; Lin SY; Luo GY; Gao XY; Shan HB
J Int Med Res; 2013 Aug; 41(4):1228-35. PubMed ID: 23801064
[TBL] [Abstract][Full Text] [Related]
17. Autofluorescence characterisation of isolated whole crypts and primary cultured human epithelial cells from normal, hyperplastic, and adenomatous colonic mucosa.
DaCosta RS; Andersson H; Cirocco M; Marcon NE; Wilson BC
J Clin Pathol; 2005 Jul; 58(7):766-74. PubMed ID: 15976349
[TBL] [Abstract][Full Text] [Related]
18. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
[TBL] [Abstract][Full Text] [Related]
19. Filiform serrated adenomas: a clinicopathologic and immunophenotypic study of 18 cases.
Yantiss RK; Oh KY; Chen YT; Redston M; Odze RD
Am J Surg Pathol; 2007 Aug; 31(8):1238-45. PubMed ID: 17667549
[TBL] [Abstract][Full Text] [Related]
20. Alteration of gene expression in macroscopically normal colonic mucosa from individuals with a family history of sporadic colon cancer.
Hao CY; Moore DH; Wong P; Bennington JL; Lee NM; Chen LC
Clin Cancer Res; 2005 Feb; 11(4):1400-7. PubMed ID: 15746039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
